The effects of SGLT2 inhibitors in patients with metabolic dysfunction-associated fatty liver diseas...
The effects of SGLT2 inhibitors in patients with metabolic dysfunction-associated fatty liver disease; a narrative review
About this item
Full title
Author / Creator
Publisher
The Lutheran University Association, Inc., dba Valparaiso University
Journal title
Language
English
Formats
Publication information
Publisher
The Lutheran University Association, Inc., dba Valparaiso University
Subjects
More information
Scope and Contents
Contents
Worldwide, metabolic dysfunction-associated fatty liver disease (MAFLD) is a significant public health concern, especially since more than fifty percent of people with type 2 diabetes are affected by it. This pathological condition includes all states of fatty liver disease, from non-alcoholic fatty liver disease (NAFLD) to steatohepatitis (NASH)....
Alternative Titles
Full title
The effects of SGLT2 inhibitors in patients with metabolic dysfunction-associated fatty liver disease; a narrative review
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1159a92fa39c430491a599852d73547d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1159a92fa39c430491a599852d73547d
Other Identifiers
ISSN
2392-7674
E-ISSN
2392-7674
DOI
10.22543/2392-7674.1439
